| |
|
|
|
|
|
|
|||
|
Blood, 1 July 2006, Vol. 108, No. 1, pp. 278-285. Prepublished online as a Blood First Edition Paper on January 12, 2006; DOI 10.1182/blood-2005-04-1567.
Submitted April 18, 2005
Inserm UR383, Paris, France * Corresponding author; email: junien{at}necker.fr.
The incidence of follicular lymphoma (FL) in industrialized countries has been increasing since the 1950s. Polymorphisms in genes encoding key enzymes controlling folate-methionine metabolism including methylenetetrahydrofolate reductase (MTHFR), methionine synthase, (MS/MTR), serine hydroxymethyl transferase (SHMT) and thymidylate synthase (TS/TYMS) modify the risk of various cancers, and possibly FL. This study is specifically looking for an association between MTHFR, MTR, TYMS and SHMT polymorphisms and the risk of FL. We carried out a case-control study with 172 patients diagnosed with FL and 206 control subjects. We report that the risk of FL was doubled by the association of one mutant allele at both MTHFR polymorphisms. MTR 2756AA individuals had 2-fold higher risk of FL and subjects not having at least one TYMS 2R allele showed a 2-fold higher risk of FL. The MTR 2756AA genotype conferred a greater multivariate-adjusted relative risk of FL, and the risk was multiplied by almost 5 in the TYMS2R(-)/MTR 2756AA combination. In conclusion, common polymorphisms in key enzymes of the folate-methionine metabolism pathway result in an increased risk of FL and suggest that inadequate intake of dietary folate and other methyl donor nutrients may contribute to the development of this malignancy.
Related Article in Blood Online:
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2006 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||